Status:
COMPLETED
A Cluster-randomized Cross-over Trial Evaluating the Comparative Effectiveness of Three Skin Antiseptic Interventions
Lead Sponsor:
University of Michigan
Collaborating Sponsors:
Blue Cross Blue Shield of Michigan Foundation
Conditions:
Bacteremia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Background: Contaminated blood cultures result in unnecessary antibiotic use, increased length of stay, and additional laboratory tests, all of which increase healthcare costs. While the optimal skin ...
Detailed Description
A group-randomized crossover trial was conducted to test the null hypothesis of no difference in blood culture contamination rates among 3 antiseptic skin preparations. The sequence of 3 different ant...
Eligibility Criteria
Inclusion
- Patient on general medical, surgical, and cardiology floors
- Receipt of a peripheral blood draw for blood culture collection
- Blood draw performed by phlebotomy team
Exclusion
- None
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
3879 Patients enrolled
Trial Details
Trial ID
NCT01216761
Start Date
May 1 2008
End Date
November 1 2009
Last Update
January 11 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.